Androlabs® is the first global pharmaceutical company solely to focus on men’s health. Androlabs traces its origins to February 2021, when Simple Pharma took over Testavan® (2% testosterone gel) and Vitaros® (alprostadil cream) from Ferring Pharmaceuticals. Our purpose is to support men along their prevention and treatment journey and to empower them to keep healthy. We are re-evaluating the traditional sales-led model of the pharma industry and are developing an alternative solution by prioritising targeted, science-led prescriber engagement and market access activities. We are now present in over 20 countries throughout Europe and Australia. Androlabs is part of the same group as Simple Pharma®, and more detail on Simple Pharma can be seen on the separate LinkedIn page. For any questions, please don't hesitate to reach out to info@andro-labs.com